在RRMS和SPMS患者中评估血清炎症指标
Maria Nowak-Kiczmer1, Natalia Niedziela1, Zenon P Czuba2
1Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Neurological research
|May 2, 2024
概括
像BAFF,gp130和骨质素这样的生物标志物在二级渐进性多发性硬化症 (SPMS) 中比复发性复发性硬化症 (RRMS) 高. 血清MMP-2在RRMS中较高,而IL-32水平根据RRMS患者的治疗状况而异.
科学领域:
- 神经免疫学 神经免疫学
- 生物化学 生化学
背景情况:
- 多发性硬化症 (MS) 是一种慢性自身免疫性炎症性疾病.
- 在治疗中,区分复发性复发性多发性硬化 (RRMS) 和继发性进展性多发性硬化 (SPMS) 是至关重要的.
- 识别生物标志物以区分多发性硬化症亚型至关重要.
研究的目的:
- 为了比较RRMS和SPMS患者之间的血清炎症参数水平.
- 识别潜在的生物标志物,以区分多发性硬化症病程.
主要方法:
- 分析了60名被诊断为MS患者 (RRMS和SPMS) 的血清样本.
- 评估了包括BAFF,gp130,骨质素,MMP-2和IL-32在内的炎症参数水平.
- 考虑了RRMS患者的治疗状况 (先前的治疗与疾病修饰疗法).
主要成果:
- 与RRMS患者相比,SPMS患者的血清BAFF,gp130和骨质素水平显著更高.
- 在RRMS患者中,血清MMP-2水平显著更高,与复发史相关.
- 在未接受治疗的RRMS患者中,血清IL-32水平高于接受疾病修饰疗法的患者.
结论:
- 特定的炎症标志物 (BAFF,gp130,骨质疏松素,MMP-2) 在RRMS和SPMS之间表现有差异.
- 血清IL-32水平可能表明RRMS的治疗反应或疾病活性.
- 这些发现突出了MS亚型分化的潜在生物标志物.
关键词:
巴夫 (BAFF) 是一个巴夫.对于IL-32来说,它是非常重要的.在MMP-2中,MMP-2是MMP-2的替代品.在RRMS中使用RRMS.这就是SPMS的原因.gp13030 的使用情况.骨质疏松剂是一种骨质疏松剂.更多相关视频
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
581
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
4.1K
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
01:20Rheumatic Heart Disease IV: Nursing Management
484
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484